Clinical trial
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD)…
NCT00110448 · Kumamoto University, Other · Completed
Key facts
| NCT number | NCT00110448 |
|---|---|
| Title | Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial |
| Official title | Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial |
| Lead sponsor | Kumamoto University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease, Arteriosclerosis, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Aspirin, No aspirin |
| Enrollment | 2,539 |
| Start date | Dec 1, 2002 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 10, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: